Phase II Trial of Metronomic Eribulin (Halaven) In Pretreated Metastatic Breast Cancer (MBC)
Phase of Trial: Phase II
Latest Information Update: 23 Oct 2019
Price : $35 *
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer; Male breast cancer
- Focus Therapeutic Use
- 17 Oct 2019 Status changed from active, no longer recruiting to completed.
- 09 Nov 2018 Planned primary completion date changed from 1 Aug 2018 to 4 May 2019.
- 22 Jun 2018 Status changed from recruiting to active, no longer recruiting.